Intensive Care, Intensive Caution: Emory And CDC Researchers Report On Microbial Resistance To Antibiotics In Hospital ICU's

April 17, 1997

The rate at which pathogens resist antimicrobial treatment is significantly higher in the hospital setting than in the outpatient setting, report researchers from Centers for Disease Control and Prevention (CDC) and Emory University's Rollins School of Public Health in Clinical Infectious Diseases.

The team found that pathogens isolated from patients in hospital intensive care units (ICUs) are most resistant to antibiotics, organisms infecting patients in other areas of the hospital were less resistant and organisms isolated from outpatients were least resistant to treatment.

'As the rate of antimicrobial resistance increases, more resources should be allocated to stem this problem within the ICU, including more surveillance activities, scrupulous and stricter infection control in hospitals, and improved use of antibiotics,' conclude first author Lennox K. Archibald, of the Hospital Infections Program, National Center for Infectious Diseases, CDC; Emory's John McGowan Jr., M.D., professor of epidemiology; and other CDC and Emory co-authors.

Data come from the National Nosocomial Infections Surveillance System (NNIS; www.cdc.gov/ncidod/diseases/hip/nnis.htm), the nation's most extensive system for tracking hospital-acquired (nosocomial) infections and for gauging how resistant nosocomial pathogens are to antimicrobials. Researchers from the Hospital Infections Program, CDC and Emory are using NNIS data for Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology). Their current paper summarizes Phase 1 of Project ICARE and includes data from eight NNIS hospitals.

Specimens isolated from inpatients and outpatients were analyzed to assess resistance levels of eight organisms to eight common antimicrobials (13 organism/antimicrobial combinations).

The group reports that pathogens from inpatients with the following organism/antimicrobial combinations resisted treatment more steadfastly than the same pathogens isolated from outpatients: 'Patients admitted to ICUs are at greatest risk of acquiring nosocomial infections, partly because of their serious underlying disease but also because of exposure to life-saving invasive procedures, prolonged use of in situ invasive devices, therapy with multiple antimicrobials, and extended hospital stays,' the authors explain. 'Moreover, antimicrobial resistance in pathogens is more likely encountered in the ICU because of the selection effect of treatment with multiple antimicrobials for a single patient, which may result in amplification of antimicrobial resistance in organisms. The increasing number of ICU beds in hospitals is an important development regarding both antimicrobial resistance and nosocomial infections. The relative magnitude of antimicrobial resistance in ICUs will increase as hospitals devote more beds and resources to those units.'

Project ICARE is sponsored by the National Foundation for Infectious Diseases; Zeneca Pharmaceuticals; American Society for Health-System Pharmacists; Bayer Corporation, Pharmaceutical Division; Rhone-Poulenc-Rorer; Roche Laboratories; and Kimberly-Clark Corporation.

Antimicrobial Resistance
Scope of the Problem


The following excerpt comes verbatim from the introduction to 'Antimicrobial Resistance in Isolates from Inpatients and Outpatients in the United States: Increasing Importance of the Intensive Care Unit' published in the journal Clinical Infectious Diseases
(Feb. 1997;24:211-5, L. Archibald et al).

'Antimicrobial-resistant pathogens are challenges to progress in controlling emerging infections, especially hospital-acquired infections'.

Increases in the rate of antimicrobial resistance are resulting in the use of much more expensive drugs, more prolonged hospitalizations, higher death-rates, and higher health care costs.

Yearly expenditures incurred from drug resistance in the United States are estimated to approach $4 billion and are rising. Most, but not all, studies have found a higher prevalence of antimicrobial resistance in hospitals in general and in intensive care units (ICUs) in particular than in the community. Such resistance presents a serious challenge for physicians.

For example, data from the National Nosocomial Infections Surveillance (NNIS) system, currently the only national source of information in infections due to hospital-acquired pathogens and their associated antimicrobial susceptibility profiles, indicate that the rate of resistance to vancomycin in hospital-acquired Enterococcus species is increasing. As of December 1993, 14.2% of all enterococci associated with nosocomial infections in ICU patients were vancomycin-resistant. Most of these pathogens were resistant to all currently available antimicrobials. Among certain gram-negative bacilli, the resistance rate is also increasing.

In hospitals participating in the NNIS system, NNIS data indicate that the percentage of Klebsiella pneumoniae resistant to extended-spectrum B-lactam agents increased from 1.5% in 1986 to 12.8% in 1993. NNIS data also suggest that in one region these resistant Klebsiella strains first appeared in an ICU in one hospital and then spread to other hospitals in the surrounding area. Unfortunately, antimicrobial resistance is not limited to the hospital setting. Streptococcus pneumoniae infections are a leading cause of morbidity and

mortality in young children, persons with underlying debilitating medical conditions, and elderly persons. Multidrug-resistant strains of this organism are emerging throughout the United States. Methicillin-resistant Staphylococcus aureus, traditionally thought to be hospital-acquired but infrequently recognized in the community for over a decade, is now found outside hospitals in relatively large numbers.

Defining appropriate control measures for antimicrobial-resistant pathogens has been of particular concern for acute care hospitals. With a changing emphasis on integrated health care systems that provide care for patients in acute care, extended care, and ambulatory care settings, dwindling resources will need to be prioritized and appropriately focused on infection control in hospitals and prevention of antimicrobial resistance. This task has been complicated by the fact that the magnitude of antimicrobial resistance in the hospital compared with that in the community setting is not clear. In addition, the contribution of the ICU to overall resistance in the hospital needs clarification. Therefore, to evaluate and compare resistance in these two settings, in 1994 the Hospital Infections Program and the Centers for Disease Control and Prevention (CDC), in cooperation with the Rollins School of Public Health at Emory University, began Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology). This project began with phase 1 in April 1994; a second phase started early in 1996.

Authors:

Lennox Archibald -- Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC).

Lisa Phillips -- doctoral student in epidemiology, Rollins School of Public Health, Emory University.

Dominique Monnet -- formerly visiting scientist at CDC, current affiliation: Statens Seruminstitut, Copenhagen, Denmark

John E. McGowan, Jr.-- professor of epidemiology, Rollins School of Public Health, and professor of pathology and laboratory medicine, School of Medicine, Emory University, Emory University.

Fred Tenover -- chief, Nosocomial Pathogens Laboratory Branch, CDC, and adjunct professor of epidemiology, Rollins School of Public Health, Emory University.

Robert Gaynes -- director, National Nosocomial Infections Surveillance System, CDC, and adjunct associate professor of epidemiology, Rollins School of Public Health, Emory University.

-end-




Emory University Health Sciences Center

Related Public Health Articles from Brightsurf:

COVID-19 and the decolonization of Indigenous public health
Indigenous self-determination, leadership and knowledge have helped protect Indigenous communities in Canada during the coronavirus disease 2019 (COVID-19) pandemic, and these principles should be incorporated into public health in future, argue the authors of a commentary in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.200852.

Public health consequences of policing homelessness
In a new study examining homelessness, researchers find that policy such a lifestyle has massive public health implications, making sleeping on the street even MORE unhealthy.

Electronic health information exchange improves public health disease reporting
Disease tracking is an important area of focus for health departments in the midst of the COVID-19 pandemic.

Pandemic likely to cause long-term health problems, Yale School of Public Health finds
The coronavirus pandemic's life-altering effects are likely to result in lasting physical and mental health consequences for many people--particularly those from vulnerable populations--a new study led by the Yale School of Public Health finds.

The Lancet Public Health: US modelling study estimates impact of school closures for COVID-19 on US health-care workforce and associated mortality
US policymakers considering physical distancing measures to slow the spread of COVID-19 face a difficult trade-off between closing schools to reduce transmission and new cases, and potential health-care worker absenteeism due to additional childcare needs that could ultimately increase mortality from COVID-19, according to new modelling research published in The Lancet Public Health journal.

The Lancet Public Health: Access to identification documents reflecting gender identity may improve trans mental health
Results from a survey of over 20,000 American trans adults suggest that having access to identification documents which reflect their identified gender helps to improve their mental health and may reduce suicidal thoughts, according to a study published in The Lancet Public Health journal.

The Lancet Public Health: Study estimates mental health impact of welfare reform, Universal Credit, in Great Britain
The 2013 Universal Credit welfare reform appears to have led to an increase in the prevalence of psychological distress among unemployed recipients, according to a nationally representative study following more than 52,000 working-age individuals from England, Wales, and Scotland over nine years between 2009-2018, published as part of an issue of The Lancet Public Health journal on income and health.

BU researchers: Pornography is not a 'public health crisis'
Researchers from the Boston University School of Public Health (BUSPH) have written an editorial in the American Journal of Public Health special February issue arguing against the claim that pornography is a public health crisis, and explaining why such a claim actually endangers the health of the public.

The Lancet Public Health: Ageism linked to poorer health in older people in England
Ageism may be linked with poorer health in older people in England, according to an observational study of over 7,500 people aged over 50 published in The Lancet Public Health journal.

Study: Public transportation use linked to better public health
Promoting robust public transportation systems may come with a bonus for public health -- lower obesity rates.

Read More: Public Health News and Public Health Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.